MENU
PRTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

PRTA is expected to report earnings to fall 19.54% to -54 cents per share on February 12

Prothena PRTA Stock Earnings Reports
Q4'25
Est.
$-0.55
Q3'25
Beat
by $0.04
Q2'25
Missed
by $1.12
Q1'25
Beat
by $0.11
Q4'24
Missed
by $0.08
The last earnings report on November 06 showed earnings per share of -68 cents, beating the estimate of -72 cents. With 679.64K shares outstanding, the current market capitalization sits at 547.99M.
View a ticker or compare two or three
PRTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRTA showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com